FR2257294A1 - - Google Patents
Info
- Publication number
- FR2257294A1 FR2257294A1 FR7324874A FR7324874A FR2257294A1 FR 2257294 A1 FR2257294 A1 FR 2257294A1 FR 7324874 A FR7324874 A FR 7324874A FR 7324874 A FR7324874 A FR 7324874A FR 2257294 A1 FR2257294 A1 FR 2257294A1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE529734D BE529734A (ja) | 1953-06-19 | ||
FR1102696D FR1102696A (fr) | 1953-06-19 | 1954-06-17 | Dispositif d'alimentation d'un circuit de consommation |
FR7324874A FR2257294B1 (ja) | 1973-07-06 | 1973-07-06 | |
NO3260/73A NO137205C (no) | 1973-07-06 | 1973-08-16 | Analogifremgangsm}te for fremstilling av piperazinpyrimidiner med terapeutisk virkning. |
LU68263A LU68263A1 (ja) | 1973-07-06 | 1973-08-20 | |
BE134751A BE803803A (fr) | 1973-07-06 | 1973-08-20 | Nouvelles piperazino-pyrimidines utilisables comme medicaments |
ES418113A ES418113A1 (es) | 1973-07-06 | 1973-08-22 | Un procedimiento para la preparacion de nuevas piperacino- pirimidinas. |
CH1213673A CH582171A5 (ja) | 1973-07-06 | 1973-08-23 | |
DE19732342880 DE2342880A1 (de) | 1973-07-06 | 1973-08-24 | Piperazin-pyrimidine, verfahren zu ihrer herstellung und ihre verwendung |
JP48100728A JPS5849548B2 (ja) | 1973-07-06 | 1973-09-06 | ピリミジン化合物誘導体の製造法 |
NLAANVRAGE7312321,A NL179257C (nl) | 1953-06-19 | 1973-09-07 | Werkwijze voor de bereiding van een geneesmiddel dat als actieve verbinding een 4-piperazinylpyrimidinederivaat bevat en werkwijze ter bereiding van daarbij te gebruiken actieve verbindingen. |
GB4286673A GB1434544A (en) | 1973-07-06 | 1973-09-12 | Piperazino-pyrimidines process for their preparation and use |
MX003804U MX2978E (es) | 1973-07-06 | 1973-11-08 | Procedimiento para la preparacion de derivados sustituidos de piperazina 5 - metil o 5 - metil tio pirimidina |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7324874A FR2257294B1 (ja) | 1973-07-06 | 1973-07-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2257294A1 true FR2257294A1 (ja) | 1975-08-08 |
FR2257294B1 FR2257294B1 (ja) | 1977-07-01 |
Family
ID=9122191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7324874A Expired FR2257294B1 (ja) | 1953-06-19 | 1973-07-06 |
Country Status (10)
Country | Link |
---|---|
JP (1) | JPS5849548B2 (ja) |
BE (1) | BE803803A (ja) |
CH (1) | CH582171A5 (ja) |
DE (1) | DE2342880A1 (ja) |
ES (1) | ES418113A1 (ja) |
FR (1) | FR2257294B1 (ja) |
GB (1) | GB1434544A (ja) |
LU (1) | LU68263A1 (ja) |
MX (1) | MX2978E (ja) |
NO (1) | NO137205C (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0063509A1 (fr) * | 1981-04-07 | 1982-10-27 | Pharmuka Laboratoires | Nouveaux dérivés de pipérazino-2 pyrimidine, procédés pour leur préparation, médicaments les contenant et leur utilisation comme intermédiaires pour la fabrication de médicaments |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7605319A (nl) * | 1975-05-23 | 1976-11-25 | Mar Pha Etu Expl Marques | Werkwijze ter bereiding van een geneesmiddel, zo gevormd geneesmiddel en werkwijze ter bereiding van geschikte geneeskrachtige verbindingen. |
FR2417507A2 (fr) * | 1977-07-28 | 1979-09-14 | Ugine Kuhlmann | Diamino-2,4 (ou -4,6) methylthio-5 pyrimidines herbicides |
JPS54159877A (en) * | 1978-06-07 | 1979-12-18 | Matsushita Electronics Corp | Detection method for semiconductor substrate position and break |
JPS6177335A (ja) * | 1984-09-25 | 1986-04-19 | Kazumichi Kimura | 半導体ペレツト不良マ−ク検出装置 |
IT1191845B (it) * | 1986-01-20 | 1988-03-23 | Dompe Farmaceutici Spa | Alchiloli derivati farmacologicamente attivi |
JPH02114936U (ja) * | 1989-03-03 | 1990-09-14 |
-
1973
- 1973-07-06 FR FR7324874A patent/FR2257294B1/fr not_active Expired
- 1973-08-16 NO NO3260/73A patent/NO137205C/no unknown
- 1973-08-20 BE BE134751A patent/BE803803A/xx not_active IP Right Cessation
- 1973-08-20 LU LU68263A patent/LU68263A1/xx unknown
- 1973-08-22 ES ES418113A patent/ES418113A1/es not_active Expired
- 1973-08-23 CH CH1213673A patent/CH582171A5/xx not_active IP Right Cessation
- 1973-08-24 DE DE19732342880 patent/DE2342880A1/de not_active Ceased
- 1973-09-06 JP JP48100728A patent/JPS5849548B2/ja not_active Expired
- 1973-09-12 GB GB4286673A patent/GB1434544A/en not_active Expired
- 1973-11-08 MX MX003804U patent/MX2978E/es unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0063509A1 (fr) * | 1981-04-07 | 1982-10-27 | Pharmuka Laboratoires | Nouveaux dérivés de pipérazino-2 pyrimidine, procédés pour leur préparation, médicaments les contenant et leur utilisation comme intermédiaires pour la fabrication de médicaments |
US4535080A (en) * | 1981-04-07 | 1985-08-13 | Pharmuka Laboratoires | Derivatives of 2-piperazino-pyrimidine, methods for their preparation and their utilization as drugs or intermediates for drugs |
Also Published As
Publication number | Publication date |
---|---|
FR2257294B1 (ja) | 1977-07-01 |
GB1434544A (en) | 1976-05-05 |
NO137205B (no) | 1977-10-10 |
CH582171A5 (ja) | 1976-11-30 |
BE803803A (fr) | 1974-02-20 |
NO137205C (no) | 1978-01-18 |
JPS5025578A (ja) | 1975-03-18 |
MX2978E (es) | 1980-01-17 |
JPS5849548B2 (ja) | 1983-11-05 |
DE2342880A1 (de) | 1975-01-30 |
ES418113A1 (es) | 1976-03-16 |
NO326073L (ja) | 1975-02-03 |
LU68263A1 (ja) | 1973-10-24 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TP | Transmission of property | ||
CD | Change of name or company name | ||
TP | Transmission of property | ||
ST | Notification of lapse |